The new guideline also included two new therapies/drugs — monoclonal antibody cocktail and Molnupiravir — for the asymptomatic but high-risk patients and symptomatic patients with certain comorbidities to prevent the disease from progressing towards severe infection.
AstraZeneca is also planning to bring Evusheld to India The company has said that it is in talks with the Centre and will provide details about its antibody cocktail to the Indian authorities that might provide adequate ammunition in the fight against COVID 19 especially for high risk vulnerable and immunocompromised patients
BMC s new Antibodies Cocktail Treatment gives sharp kick to Covid prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.
New Delhi, June 26: A single-day rise of 48,698 Covid-19 infections took India's case tally to 3,01,83,143 while the weekly positivity rate declined to 2.97 per cent, according to Union Health Ministry data on Saturday.